Michael Simoff has been a senior staff physician at Henry Ford Hospital for more than 20 years. He is the past Director of the Pulmonary Function and Exercise Physiology Laboratories as well as the Pulmonary Rehabilitation programs throughout our system. He has been practicing interventional pulmonology for his entire career and currently he is the Director of Bronchoscopy and Interventional Pulmonology, as well as Director of Lung Cancer Screening for HFHS. The airway therapeutic program is the busiest in the United States. He is actively involved in new technology development and applied and translational research.
Bronchoscopic Lung Volume Reduction for Emphysema
Dr. Dong is a Professor of environmental epidemiology and environmental toxicology. He has years of experience working as an environmental epidemiologist in China and his research areas of focus include adults and child health, environmental health, exposure assessment, indoor and outdoor air pollution. Also, His research area focused on the toxicological evaluation of some components in PM10 and PM2.5, such as some persistent organic pollutant (PFOS, PBDEs) in ambient air particles. So far, Dr. Dong has published more than 120 papers in the international journals including Lancet Planetary Health, JAMA Network Open, EHP, Thorax, Allergy, Hypertension, etc. journals as first and corresponding author.
Jan De Backer graduated from Delft University of Technology, The Netherlands as aerospace engineer. He attained an MSc degree in aerodynamics and specialized in applied biomedical computational fluid dynamics leading to a PhD from the University of Antwerp, Belgium. He is an alumnus of the MBA programs at London Business School, London and Columbia Business School, New York. De Backer has received several awards for his innovative research in the field of airway modeling in respiratory and sleep medicine. His work has been published in international journals. De Backer founded FLUIDDA in 2005 and he has held the position of Chief Executive Officer since 2007.
Dr. Mina is Director of the Pulmonary Critical Care Fellowship Program, and Section Chief for Pulmonary Medicine at Lenox Hill Hospital. Dr. Mina is an Assistant Clinical Professor at Zucker Scholl of Medicine at Hosfstra. He is a key faculty member in the department of Internal Medicine and Vascular Surgery Fellowship Program. Dr. Mina is a graduate of Medical School, Alexandria University. He finished his Critical Care fellowship at Memorial Sloan Kettering Cancer Center, and Pulmonary Critical Care Fellowship at St. Vincent Hospital and Medical Center in New York. Other degrees include European Diploma of Intensive Care Medicine, and Diploma of Tropical Diseases, Royal College of Surgeons, Dublin, Ireland. Main Research interest include noninvasive ventilation, thromboembolic disease, and COPD. His research experiences include multiple presentations, publication of abstracts, papers, and book chapters that address different topics of pulmonary and critical care medicine.
Dr. John Klir is an American trained MD/PhD medical scholar with combined experience of more than 25 years in academic medicine, medical research, clinical medicine, and administration. After obtaining his undergraduate degree in life sciences from Cornell University, Dr. Klir pursued his further studies and obtained his PhD degree in physiology from University of Illinois, and his MD degree from Saba University School of Medicine. After completing his studies, Dr. Klir continued with postgraduate training in both, medical research and clinical medicine. He trained at University of Michigan School of Medicine under mentorship of world renowned medical scholars in areas of immunopathophysiology, namely roles of pro-inflammatory cytokines as immune mediators during fever generation as a part of acute-phase response to infection. Dr. Klir’s continued work resulted in significant contribution to area of cytokine research, as evidenced by multiple publications and presentations at different international conferences. The main interest of Dr. Klir continues in areas of pro-inflammatory mediators, their role during development of different diseases, and development of treatments. During his work, Dr. Klir has been associated with various institutions, including University of Michigan Medical Center, Lovelace Biomedical Institute, University of Missouri, USDA-ARS, Pennington Biomedical Institute, University of Kansas School of Medicine, and Underwood Memorial Hospital.